K Hokynar1, S Korhonen1, P Norja1,2, J Paavonen3, M Puolakkainen4. 1. Virology, University of Helsinki and Helsinki University Hospital, Helsinki, Finland. 2. Bayer Healthcare, ext Secret Files, Äyritie 16, 01510, Vantaa, Finland. 3. Department of Obstetrics and Gynecology, Helsinki University Central Hospital, Helsinki, Finland. 4. Virology, University of Helsinki and Helsinki University Hospital, Helsinki, Finland. mirja.puolakkainen@helsinki.fi.
Abstract
We studied whether antibody to two chlamydial proteins (TroA and HtrA) could be used as biomarkers of Chlamydia trachomatis infection. METHODS: Recombinant proteins C. trachomatis TroA and HtrA were used as antigens in enzyme immunoassay (EIA). Both IgG and IgA antibody responses were studied. RESULTS: IgG or IgA antibody to either protein was infrequently detected in sera from healthy blood donors or virgin girls. Patients attending the STI Clinic and patients with perihepatitis had often IgG antibody against TroA (25 and 50 % respectively) and HtrA (21 and 38 % respectively). Especially in sera from patients with chlamydial perihepatitis, the A450nm values with TroA were high (mean 1.591). A positive correlation between C. trachomatis MIF antibody and TroA (r = 0.7) as well as HtrA (r = 0.5) antibody was observed in sera from STI clinic patients and perihepatitis patients. Individuals with C. trachomatis infection and positive serology already when seeking medical attention had higher A450nm values for TroA (0.638) and HtrA (0.836) than patients with no marker of previous exposure or with no infection (0.208 and 0.234 respectively). Diagnosis of genital C. trachomatis infection is often NAAT-based, whereas serology has little value in testing for uncomplicated genital C. trachomatis infection. TroA and HtrA antibodies are potential biomarkers for evaluation of ascending and repeated C. trachomatis infection.
We studied whether antibody to two chlamydial proteins (TroA and HtrA) could be used as biomarkers of Chlamydia trachomatis infection. METHODS: Recombinant proteins C. trachomatis TroA and HtrA were used as antigens in enzyme immunoassay (EIA). Both IgG and IgA antibody responses were studied. RESULTS: IgG or IgA antibody to either protein was infrequently detected in sera from healthy blood donors or virgin girls. Patients attending the STI Clinic and patients with perihepatitis had often IgG antibody against TroA (25 and 50 % respectively) and HtrA (21 and 38 % respectively). Especially in sera from patients with chlamydial perihepatitis, the A450nm values with TroA were high (mean 1.591). A positive correlation between C. trachomatis MIF antibody and TroA (r = 0.7) as well as HtrA (r = 0.5) antibody was observed in sera from STI clinic patients and perihepatitispatients. Individuals with C. trachomatis infection and positive serology already when seeking medical attention had higher A450nm values for TroA (0.638) and HtrA (0.836) than patients with no marker of previous exposure or with no infection (0.208 and 0.234 respectively). Diagnosis of genital C. trachomatis infection is often NAAT-based, whereas serology has little value in testing for uncomplicated genital C. trachomatis infection. TroA and HtrA antibodies are potential biomarkers for evaluation of ascending and repeated C. trachomatis infection.
Authors: Scott H Stansfield; Pooja Patel; Joseph Debattista; Charles W Armitage; Kelly Cunningham; Peter Timms; John Allan; Aruna Mittal; Wilhelmina M Huston Journal: Results Immunol Date: 2013-05-13
Authors: Nicole M Budrys; Siqi Gong; Allison K Rodgers; Jie Wang; Christopher Louden; Rochelle Shain; Robert S Schenken; Guangming Zhong Journal: Obstet Gynecol Date: 2012-05 Impact factor: 7.661
Authors: Jane E Raulston; Jeffrey D Miller; Caroyn H Davis; Maria Schell; Amy Baldwin; Kaethe Ferguson; Heather Lane Journal: FEMS Immunol Med Microbiol Date: 2007-12
Authors: T Rantsi; P Joki-Korpela; K Hokynar; I Kalliala; H Öhman; H-M Surcel; J Paavonen; A Tiitinen; M Puolakkainen Journal: Eur J Clin Microbiol Infect Dis Date: 2018-05-18 Impact factor: 3.267
Authors: K Shamsur Rahman; Toni Darville; Ali N Russell; Catherine M O'Connell; Harold C Wiesenfeld; Sharon L Hillier; De'Ashia E Lee; Bernhard Kaltenboeck Journal: mSphere Date: 2018-08-01 Impact factor: 4.389
Authors: K Shamsur Rahman; Toni Darville; Harold C Wiesenfeld; Sharon L Hillier; Bernhard Kaltenboeck Journal: mSphere Date: 2018-11-07 Impact factor: 4.389
Authors: Rami Mazraani; Peter Timms; Philip C Hill; Tamaailau Suaalii-Sauni; Tavita Niupulusu; Seiuli V A Temese; Liai Iosefa-Siitia; Leveti Auvaa; Siuomatautu A Tapelu; Maauga F Motu; Antoinette Righarts; Michael S Walsh; Luk Rombauts; John A Allan; Patrick Horner; Wilhelmina M Huston Journal: Pathog Dis Date: 2019-04-01 Impact factor: 3.166
Authors: Katrin Hufnagel; Bernice Hoenderboom; Christoph Harmel; Juliane K Rohland; Birgit H B van Benthem; Servaas A Morré; Tim Waterboer Journal: Microorganisms Date: 2019-12-16